Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy

Nephrology

Volumn 15, Issue 2, 2010, Pages 216-224

  Han, Dong He ^a   Song, Hyun Kuk ^a   Lee, So Young ^a   Song, Ji Hyun ^a   Piao, Shang Guo ^a   Yoon, Hye Eun ^a   Ghee, Jung Yeon ^a   Yoon, Hyung Ju ^a   Kim, Jin ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

CD44; Cyclosporine A; Fibrosis; Hyaluronan; LYVE 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLOSPORIN A; ED 1 RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; LYMPHATIC VASCULAR ENDOTHELIAL HYALURONIC ACID RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBROSING ALVEOLITIS; IMMUNOREACTIVITY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SODIUM RESTRICTION;

ACTINS; ANIMALS; ANTIGENS, CD44; CHRONIC DISEASE; CYCLOSPORINE; DIET, SODIUM-RESTRICTED; DISEASE MODELS, ANIMAL; FIBROSIS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; TIME FACTORS; UP-REGULATION;

EID: 77749324189     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01167.x     Document Type: Article

References (35)

1. de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am. J. Kidney Dis. 2000 35 : 333 346.
2. Bohle A, Mackensen-Haen S, Von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am. J. Nephrol. 1987 7 : 421 433.
3. Al'Qteishat A, Gaffney J, Krupinski J et al. Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 2006 129 : 2158 2176.
4. George J, Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin. Chim. Acta 2004 348 : 189 197.
5. Wüthrich RP. The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol. Dial. Transplant. 1999 14 : 2554 2556.
6. Almond A. Hyaluronan. Cell. Mol. Life Sci. 2007 64 : 1591 1596.
7. McKee CM, Penno MB, Cowman M et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 1996 98 : 2403 2413.
8. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 2000 12 : 581 586.
9. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 1990 2 : 839 844.
10. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990 61 : 1303 1313.
11. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol. 1994 6 : 726 733.
12. Funaro A, Spagnoli GC, Momo M, Knapp W, Malavasi F. Stimulation of T cells via CD44 requires leukocyte-function-associated antigen interactions and interleukin-2 production. Hum. Immunol. 1994 40 : 267 278.
13. Oksala O, Salo T, Tammi R et al. Expression of proteoglycans and hyaluronan during wound healing. J. Histochem. Cytochem. 1995 43 : 125 135.
14. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 1999 144 : 789 801.
15. Gale NW, Prevo R, Espinosa J et al. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol. Cell. Biol. 2007 27 : 595 604.
16. Hällgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J. Exp. Med. 1990 171 : 2063 2076.
17. Göransson V, Hansell P, Moss S et al. Renomedullary interstitial cells in culture; the osmolality and oxygen tension influence the extracellular amounts of hyaluronan and cellular expression of CD44. Matrix Biol. 2001 20 : 129 136.
18. Knepper MA, Saidel GM, Hascall VC, Dwyer T. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer. Am. J. Physiol. Renal Physiol. 2003 284 : F433 46.
19. Declèves AE, Caron N, Nonclercq D et al. Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int. J. Mol. Med. 2006 18 : 83 94.
20. Pedagogos E, Hewitson TD, Nicholls KM, Becker GJ. Hyaluronan and rat renal fibroblasts: in vitro studies. Nephron 2001 88 : 347 353.
21. Lewington AJ, Padanilam BJ, Martin DR, Hammerman MR. Expression of CD44 in kidney after acute ischemic injury in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000 278 : R247 54.
22. Sibalic V, Fan X, Loffing J, Würthrich RP. Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol. Dial. Transplant. 1997 12 : 1344 1353.
23. Wells A, Larsson E, Hanás E, Laurent T, Hällgren R, Tufveson G. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993 55 : 1346 1349.
24. Wells AF, Larsson E, Tengblad A et al. The localization of hyaluronan in normal and rejected human kidneys. Transplantation 1990 50 : 240 243.
25. Sano N, Kitazawa K, Sugisaki T. Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathy. Nephron 2001 89 : 416 421.
26. Rydell N. Decreased granulation tissue reaction after installment of hyaluromic acid. Acta Orthop. Scand. 1970 41 : 307 311.
27. Jun Z, Hill PA, Lan HY et al. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin. Exp. Immunol. 1997 108 : 69 77.
28. DeGrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J. Exp. Med. 1996 183 : 1119 1130.
29. Green SJ, Tarone G, Underhill CB. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. Exp. Cell Res. 1988 178 : 224 232.
30. Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG. Epican, a heparin/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J. Cell Sci. 1994 107 : 3183 3190.
31. Rouschop KM, Sewnath ME, Claessen N et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 2004 15 : 674 686.
32. Zheng Z, Katoh S, He Q et al. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 1995 130 : 485 495.
33. Huang SS, Liu IH, Smith T, Shah MR, Johnson FE, Huang JS. CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels. FEBS Lett. 2006 580 : 6259 6268.
34. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 2007 282 : 33671 33680. (Pubitemid 350159526)
35. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am. J. Pathol. 2007 170 : 1178 1191.